Phase II trial of LGT 209 in patients with hypercholesterolaemia.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2013
At a glance
- Drugs LGT 209 (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2013 Status changed from recruiting to discontinued, based on information in Novartis' 20-F form (http://www.novartis.com/downloads/newsroom/corporate-publications/Novartis-20-F-2012.pdf).
- 06 Jan 2012 New trial record